Gastric Cancer Signaling Pathways and Therapeutic Applications

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Gastric cancer (GC) is a significant global health challenge, ranking as the second leading cause of cancer-related mortality.
• High incidence and poor prognosis are attributed to late detection and limitations of conventional treatments like chemotherapy, radiotherapy, and surgery.
• Existing therapies often yield unsatisfactory curative effects, contributing to a low 5-year survival rate for GC patients.

Purpose of the Study:

• To review the key signaling pathways implicated in gastric cancer development.
• To summarize recent advancements in targeted therapy and immunotherapy for GC.
• To offer novel insights for enhancing the clinical treatment of gastric cancer.

Main Methods:

• Literature review of current research on gastric cancer signaling pathways.
• Analysis of recent studies on targeted therapy and immunotherapy applications in GC.
• Synthesis of findings to identify promising therapeutic strategies.

Main Results:

• Identification of critical signaling pathways driving GC progression.
• Overview of emerging targeted agents and immunotherapeutic approaches showing promise.
• Highlighting the potential of these novel therapies to overcome limitations of traditional treatments.

Conclusions:

• Targeted therapy and immunotherapy represent promising frontiers in gastric cancer treatment.
• Understanding specific signaling pathways is crucial for developing effective personalized therapies.
• Further research and clinical application of these strategies could significantly improve patient survival rates and outcomes.